Trial Profile
Zotarolimus- versus sirolimus- versus paclitaxel-eluting stents for the prevention of coronary artery restenosis in patients with acute coronary syndromes or stable angina undergoing percutaneous coronary intervention
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Aug 2012
Price :
$35
*
At a glance
- Drugs Zotarolimus (Primary) ; Paclitaxel; Sirolimus
- Indications Acute coronary syndromes; Angina pectoris; Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms ZEST
- 11 Nov 2011 Serial angiographic follow-up results presented at the 23rd Annual Scientific Symposium on Transcatheter Cardiovascular Therapeutics.
- 23 Feb 2011 New trial record